Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance INFI opened at $0.02 on Tuesday. The stock has a market cap of $1.91 million, a price-to-earnings ratio of -0.05 and a […]